Your browser doesn't support javascript.
loading
Crystal structures of human glyoxalase I and its complex with TLSC702 reveal inhibitor binding mode and substrate preference.
Usami, Midori; Ando, Koki; Shibuya, Asuka; Takasawa, Ryoko; Yokoyama, Hideshi.
Afiliação
  • Usami M; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
  • Ando K; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
  • Shibuya A; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
  • Takasawa R; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
  • Yokoyama H; Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan.
FEBS Lett ; 596(11): 1458-1467, 2022 06.
Article em En | MEDLINE | ID: mdl-35363883
ABSTRACT
Human glyoxalase I (hGLO I) is an enzyme for detoxification of methylglyoxal (MG) and has been considered an attractive target for the development of new anticancer drugs. In our previous report, the GLO I inhibitor TLSC702 induced apoptosis in tumor cells. Here, we determined the crystal structures of hGLO I and its complex with TLSC702. In the complex, the carboxyl O atom of TLSC702 is coordinated to Zn2+ , and TLSC702 mainly shows van der Waals interaction with hydrophobic residues. In the inhibitor-unbound structure, glycerol, which has similar functional groups to MG, was bound to Zn2+ , indicating that GLO I can easily bind to MG. This study provides a structural basis to develop better anticancer drugs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lactoilglutationa Liase / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lactoilglutationa Liase / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article